Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity
Ziva Pogacar(The Netherlands Cancer Institute), Rodrigo Leite de Oliveira(The Netherlands Cancer Institute), René Bernards(The Netherlands Cancer Institute), Olaf van Tellingen(Dutch Cancer Society), Giulia De Conti(Politecnico di Milano), Ji‐Ying Song(Oncode Institute), Roderick L. Beijersbergen(The Netherlands Cancer Institute), Kelvin Groot(The Netherlands Cancer Institute), Arno Velds(The Netherlands Cancer Institute), Lenno Krenning(The Netherlands Cancer Institute), René H. Medema(Princess Máxima Center), Fleur Jochems(The Netherlands Cancer Institute), Arnout Schepers(The Netherlands Cancer Institute), Cor Lieftink(Cancer Genomics Centre), Liqin Wang(Nanjing Medical University), Leyma Wardak(The Netherlands Cancer Institute), Jackie Johnson(University of South Florida), Marieke van de Ven(The Netherlands Cancer Institute)
Cited by 13
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k